David Landman - Publications, H-index & Citations

David Landman

state university of new york (suny) system

43H指数

159论文数

7.7K被引数

收录论文 53

发表时间

Bactericidal activity of antibiotic combinations against clinical isolates of Enterococcus gallinarum and Enterococcus casseliflavus 肠球菌属鸡肠球菌和奶酪黄肠球菌临床分离株对复方抗生素的杀菌活性

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2025-03-25

PREAI

Landman, David; Cherniak, Meir; Gefen, Orit; Michael-Gayego, Ayelet; Motro, Yair; Moran-Gilad, Jacob; Strahilevitz, Jacob

Relationship of TonB-dependent receptors with susceptibility to cefiderocol in clinical isolates of Pseudomonas aeruginosa

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2022-02-05

PREAI

Gupta, Aanchal; Landman, David; Quale, John

Trends in Healthcare Facility-Onset Clostridioides difficile Infection and the Impact of Testing Schemes in an Acute Care Hospital System in New York City, 2016-2019 2016至2019纽约市一家急症医院系统的医疗机构发病艰难梭菌感染趋势和检测方案的影响

AMERICAN JOURNAL OF INFECTION CONTROL

IF2.4

2021-10-01

PREAI

Episcopia, Briana; Gupta, Aanchal; Fornek, Mary; Kaminski, Monica; Malik, Saquib; Sunny, Subin; Landman, David; Xavier, Geralda; Quale, John

Trends in central-line-associated bloodstream infections and catheter-associated urinary tract infections in a large acute-care hospital system in New York City, 2016-2019

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

IF3

2020-11-19

PREAI

Kaminski, Monica A.; Episcopia, Briana; Malik, Saquib; Fornek, Mary; Landman, David; Xavier, Geralda; Quale, John

Cefiderocol Resistance in Acinetobacter baumannii: Roles of β-Lactamases, Siderophore Receptors, and Penicillin Binding Protein 3

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2020-10-20

OAAI

Malik, Saquib; Kaminski, Monica; Landman, David; Quale, John

Activity of Meropenem with a Novel Broader-Spectrum β-Lactamase Inhibitor, WCK 4234, against Gram-Negative Pathogens Endemic to New York City 美罗培南与新型广谱 β-内酰胺酶抑制剂WCK 4234对纽约市流行的革兰氏阴性病原体的活性

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2019-12-20

OAAI

Iregui, Alejandro; Khan, Zeb; Landman, David; Quale, John

Emergence of Delafloxacin-Resistant Staphylococcus aureus in Brooklyn, New York

CLINICAL INFECTIOUS DISEASES

IF7.3

2019-08-15

PREAI

Iregui, Alejandro; Khan, Zeb; Malik, Saquib; Landman, David; Quale, John

Activity of cefepime/zidebactam (WCK 5222) against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii endemic to New York City medical centres

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2019-07-11

PREAI

Khan, Zeb; Iregui, Alejandro; Landman, David; Quale, John

Carbapenemases in New York City: the continued decline of KPC-producing Klebsiella pneumoniae, but a new threat emerges

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2018-08-10

OAAI

Iregui, Alejandro; Ha, Karen; Meleney, Katharine; Landman, David; Quale, John

Perirectal Screening for Carbapenem-Resistant Enterobacteriaceae Obtained From 100 Consecutive Healthy Pregnant Women in Labor at a Brooklyn Hospital: Results and Risk Factors

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

IF3

2018-01-23

OAAI

Rawstron, Sarah A.; Jackman, Janelle M.; Serebro, Elena; Johnson, Gail; Cabbad, Michael; Bromberg, Kenneth; Kondamudi, Vasantha; Sepkowitz, Doug; Landman, David

In vitro and in vivo activity of single and dual antimicrobial agents against KPC-producing Klebsiella pneumoniae

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2017-11-23

OAAI

Nath, Sarath; Moussavi, Farzad; Abraham, Daniel; Landman, David; Quale, John

Rise and fall of KPC-producing Klebsiella pneumoniae in New York City

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2016-06-26

OAAI

Abdallah, Marie; Olafisoye, Olawole; Cortes, Christopher; Urban, Carl; Landman, David; Ghitan, Monica; Collins, BeverlyAnn; Bratu, Simona; Quale, John

Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2015-08-01

173

OAAI

Lapuebla, Amabel; Abdallah, Marie; Olafisoye, Olawole; Cortes, Christopher; Urban, Carl; Landman, David; Quale, John

Activity of Meropenem Combined with RPX7009, a Novel β-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York City

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2015-08-01

157

OAAI

Lapuebla, Amabel; Abdallah, Marie; Olafisoye, Olawole; Cortes, Christopher; Urban, Carl; Quale, John; Landman, David

Reduction in the prevalence of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in New York City

AMERICAN JOURNAL OF INFECTION CONTROL

IF2.4

2015-06-01

PREAI

Abdallah, Marie; Olafisoye, Olawole; Cortes, Christopher; Urban, Carl; Charles, Clayton; Landman, David; Quale, John

Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2015-03-01

118

OAAI

Abdallah, Marie; Olafisoye, Olawole; Cortes, Christopher; Urban, Carl; Landman, David; Quale, John

Success of an Infection Control Program to Reduce the Spread of Carbapenem-Resistant Klebsiella pneumoniae

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

IF3

2015-01-02

174

PREAI

Kochar, Sandeep; Sheard, Timothy; Sharma, Roopali; Hui, Alan; Tolentino, Elaine; Allen, George; Landman, David; Bratu, Simona; Augenbraun, Michael; Quale, John

Are community environmental surfaces near hospitals reservoirs for gram-negative nosocomial pathogens?

AMERICAN JOURNAL OF INFECTION CONTROL

IF2.4

2014-04-01

PREAI

Rose, Michael; Landman, David; Quale, John

Irreproducible and Uninterpretable Polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenes

JOURNAL OF CLINICAL MICROBIOLOGY

IF5.4

2013-12-01

OAAI

Landman, David; Salamera, Julius; Quale, John